CC BY
39DOI: https://doi.org/10.21323/2414-438X-2020-5-2-12-19
/©¡creative ^commons
Available online at https://www.meatjournal.ru/jour
Review paper
BIOLOGICALLY ACTIVE PEPTIDES OF MEAT AND MEAT PRODUCT PROTEINS: A REVIEW
PART 2. FUNCTIONALITY OF MEAT BIOACTIVE PEPTIDES
Irina M. Chernukha1, Natal'ya G. Mashentseva2*, Dmitrii A. Afanasev2, Natal'ya L. Vostrikova1
1 V.M. Gorbatov Federal Research Center for Food Systems of the Russian Academy of Sciences, Moscow, Russia 2 Moscow State University of Food Production, Moscow, Russia
Keywords: biologically active peptides, meat proteins, the functionality, ACE-I, antioxidant activity, antithrombotic activity, antimicrobial activity, anticancer effect, opioid effect, bioavailability
Abstract
Biologically active peptides (BAP) are regarded as the main products of protein hydrolysis. BAP activity depends on the amino acid sequence molecular weight and chain length, type and charge of an amino acid at the N-terminus and C-terminus, hydrophobic and hydrophilic properties, spatial structure. They positively influence many systems of the human body, including the blood circulatory, nervous, immune, gastrointestinal and other systems. The health-improving effect of bioactive peptides is formed due to their antioxidant, antihypertensive, antithrombotic, immunomodulatory, antimicrobial, anti-allergic, opioid, anti-inflammatory, hypocholesterolemic and anticancer properties. Angiotensin-I-converting enzyme (ACE) inhibitory peptides are most studied due to their effect on blood pressure regulation. Unlike synthetic preparations, biologically active peptides do not have side effects and, therefore, can be used as their alternative. There is a growing commercial interest in peptides generated from meat proteins is in the context of health saving functional foods. The paper describes prospects, pros and cons of using bioactive peptides as functional food ingredients and biologically active food additives.
Funding: The study was financed by the grant of the Russian Scientific Foundation (Project No.16-16-10073n) and the Program of the fundamental scientific research of the state academies of sciences 013.20.05.
Introduction
Native amino acid sequences and peptides generated during meat autolysis or enzymolysis can be functionally active. Bioactive peptides (BAPs) can be generated during thermal or other technological processing. Bioactive peptides with the antioxidant, antithrombotic, antimicrobial, hypotensive, immunomodulatory, opioid and other biological effects, which have curative or preventive impact on pathogenesis of several diseases, have been discovered and studied [1,2,3,4].
A significant number of peptides with different activities have already been isolated from meat raw materials. These peptides contain 2 to 9 (to 25 sometimes) hydrophobic amino acid residues in a strict sequence [5]. Many of them were obtained by both in vivo and in vitro proteolysis with enzymes of different origin [6].
At present, the interaction between the activity and structure of peptides has been studied. The peptide activity depends on the amino acid sequence, molecular weight and chain length, type and charge of an amino acid at the N-terminus and C-terminus, hydrophobic and hydrophilic properties, spatial structure, etc. Peptides with higher ACE inhibitory activity usually have aromatic or basic amino acids at the N-terminus, more hydrophobic and positively charged amino acids at the C-terminus [7].
Many natural BAPs structurally differ from those formed as a result of the protein post-translational modification. They
contains non-protein amino acids (^-alanin, y-aminobutyric acid), D-amino acids, alkylated amino acids. The H-pep-tide bonds and cyclic structures are the characteristic of low molecular weight peptides. Along with residues of pyroglutamic acid, they provide protection from proteases with substrate specificity to peptides from a-amino acids with normal bonds, which allows retention of peptide functionality up to the moment of their absorption [1,8].
Main part
1. Angiotensin-I-converting enzyme (ACE) inhibitory
peptides
Angiotensin-I-converting enzyme (ACE) inhibitory peptides are the most studied meat BAPs, probably due to their effect on blood pressure regulation. ACE-I is an enzyme dipeptidyl carboxypeptidase, which converts angiotensin-I (decapeptide) into angiotensin-II (octapeptide), which leads to constriction of arteries and, consequently, to an increase in blood pressure. In this connection, ACE inhibition can be linked with prophylaxis of cardiovascular diseases [9,10].
ACE-I inhibitory peptides are small peptides with 2 to 20 amino acids. Their function depends on a protein, conditions and a degree of hydrolysis, molecular weight and amino acid composition, as well as a position of amino acids in peptide sequences. ACE-I inhibitory peptides have hydrophobic amino acids and branched-chain amino acids in their structure [11,12].
FOR CITATION: Chernukha I. M., Mashentseva N. G., Afanasev D. A., Vostrikova N. L. Biologically active peptides of meat and meat product
proteins: a review. Part 2. Functionality of meat bioactive peptides. Theory and practice of meat processing. 2020; 5(2): 12-19. DOI: https://doi.org/10.21323/2414-438X-2020-5-2-12-19.
Katayama et al. found two ACE-I peptides (KRQKYD, EKERERQ), which showed the hypotensive activity on rats. They were obtained by hydrolysis of pork with pepsin [13].
The other peptide with similar function, RMLGQTPTK (44-52 position of troponin C) was also isolated by treatment of a porcine skeletal muscle with pepsin [14].
Using pepsin and pancreatin, 22 ACE-I peptides were isolated; peptide sequences KAPVA and PTPVP showed the highest antihypertensive effect [15].
Peptides with ACE inhibitory activity were found in the hydrolysate of a porcine skeletal muscle as a result of the complex digestion by eight enzymes — proteases. Peptides MNPPK and ITTNP showed the highest activity [16].
Peptides isolated from connective tissue were also identified as ACE inhibitors. Bioactivity of collagen peptides depend on the quantity of glycine and proline [17].
Properties with ACE-I effect were found in vitro and in vivo in peptides AKGANGAPGIAGAPGFPGARGPS-GPQGPSGPP and PAGNPGADGQPGAKGANGAP isolated from a hydrolysate of bovine Achilles tendon collagen using bacterial collagenase. Both peptides showed the ACE-I activity in rats [18].
Peptides from beef tendons (GPRGF, SPLPPPE, EG-PQGPPGPVG and PGLIGARGPPGP), which showed high ACE- and renin-inhibitory activities, were also identified [19,20].
Peptides with the in vivo ACE-I activity were isolated from chicken collagen treated with protease from Aspergillus oryzae [21].
Peptides from protein hydrolysate of a mixture of chicken combs and wattles were obtained by enzymatic hydrolysis. The protein hydrolysate showed the anticoagulant capacity and high ACE-inhibitory activity. The peptides were identified by LC-MS sequencing. From the pool of sequenced peptides, three peptides were selected and synthesized based on their low molecular weight and the presence of amino acids with ACE-inhibitory potential at the C-terminus: peptide I (APGLPGPR), peptide II (Piro-GPPGPT), and peptide III (FPGPPGP). Peptide III demonstrated the highest ACE-inhibitory capacity [22].
ACE-inhibitory peptides were found in hemoglobin. For example, peptides LGFPTTKTYFPHF and VVYPWT, which corresponded to the 34-46 fragment of the a-chain and the 34-39 fragment of the ^-chain of porcine hemoglobin, were obtained by hydrolysis of pork blood with pepsin [23].
2. Peptides with antioxidant activity
It is known that antioxidants are beneficial for human health as they can protect the body from molecules known as reactive oxygen species (ROS), which can attack membrane lipids, proteins and DNA. Antioxidant peptides were found in many food products including milk, wheat, potato and mushrooms. The antioxidant activity of peptides can be determined by their ability to reduce stable radical 2,2-diphenyl-1-picrylhydrazyl (DPPH assay) [24].
Over the last several years, many studies have been focused on antioxidant peptides obtained from fish, while studies on antioxidant peptides from hydrolysates of farm animal's muscles are limited [25].
Two peptides that inhibited linoleic acid autoxidation in the model system were identified in the extract of chicken essence extract. The first peptide HVTEE with the induction period of 2.49 days, the second PVPVEGV had the induction period of 6.5 days [26].
The hydrolysate with the potent antioxidant activity was obtained after cleavage of venison with papain. Two peptides that inactivate hydroxyl, DPPH, superoxide, and peroxyl radicals were identified: APVPH I (MQIFVKTLTG) and APVPH II (DLSDGEQGVL) [27].
Several peptides isolated from meat have the antioxidant activity due to their ability to inhibit lipid peroxidation, chelate metal ions, inactivate free radicals and reactive oxygen species [28,29].
The most important antioxidants natively existing in meat are dipeptides carnosine and anserine, which show their antioxidant activity chelating pro-oxidative metals [30].
Also, peptides with the antioxidant activity can be generated by hydrolysis of meat raw materials with certain proteases.
Saiga et al. [30] in studies in vitro of porcine myofibrillar proteins hydrolyzed with papain and actinase E, found five peptides (DSGVT, IEAEGE, EELDNALN, VPSIDDQEELM and DAQEKLE), which showed antioxidant activity using the in the linolenic acid peroxidation system.
Three peptides (ALTA, SLTA and VT) obtained from actomyosin of porcine skeletal muscles actomyosin showed the antioxidant activity in rats not only in vitro but also in vivo in rats [31].
Li et al. [32] isolated four antioxidant peptides (QGAR, LQGM, LQGMH and LC) from pork collagen using animal, plant and microbial enzymes (pepsin, papain, protease from bovine pancreas and bacterial proteases from Streptomyces spp. and Bacillus polymyxa) in different combinations.
Banerjee and Shanthi [18] isolated a peptide from bovine tendon collagen that consisted of contains 36 amino acid residues. Peptide was able to inactivate free radicals and chelate metals, from bovine tendon collagen.
Peptides with the antioxidant activity can be found in finished meat products. For example, 27 antioxidant peptides from Spanish dry-cured ham were sequenced using LC-MS/MS [33]. The highest activity was revealed in peptides SAGNPN and GLAGA.
Broncano et al. [34] isolated two peptides FGG and DM with the antioxidant activity from pork «chorizo» sausages.
Xing et al. [35] described several antioxidant peptides from dry-cured Xuanwei ham. Peptide DLEE was with the highest antioxidant activity.
3. Peptides with antithrombotic properties
Peptides that inhibit aggregation of blood platelets are recommended as diet components facilitating prophylaxis of thrombosis, which often occurs in patients with
ischemic heart disease or other diseases of the blood circulatory system. One of the stages of platelet aggregation is non-covalent binding of the a- and ^-fibrin chains (fibrin polymerization). The N-terminal fragment with the sequence GRP of the a-chain is the key factor of fibrin polymerization [36].
Luzak et al. [37] found that DGEA (Asp-Gly-Glu-Ala) sequence is type I collagen recognition motif, which significantly inhibited blood platelets adhesion, aggregation and release reaction by collagen.
Morimatsu et al. [38] and Shimizu et al. [39] isolated peptides that showed the antithrombotic activity from porcine muscle longissimus dorsi hydrolyzed with papain. In particular, Shimizu et al. [39] examined antithrombotic activity both in vitro by the platelet function test using rat blood and in vivo by oral administration to mice at a dose of 70 mg/kg body weight. The in vivo results showed that meat the peptide significantly reduced carotid artery thrombosis and the platelet activity and the effect is comparable to aspirin treatment at a dose of 50 mg/kg body weight.
4. Hypocholesterolemicpeptide
Increased cholesterol concentrations in plasma are linked with an increased risk of cardiovascular diseases. Cholesterol enhances lipid peroxidation, protein oxidation and generation of free radicals (H2O2), disrupts the antioxidant system (SOD, CAT, GPx and GSH), as well as the activity of ATPase and causes histopathological disorders. Bioactive peptides can be regarded as an alternative for prophylaxis or treatment of these disorders. Peptides identified as hypocholesterolemic include lactostatin (IIAEK), enterostatin (VPDPR), peptides DPR, LPYP and LPLPR [40]. It is assumed that peptides of this type have different mechanisms of action and can increase excretion of bile acids with feces, bind with phospholipids and exert the activity of the cholesterol level reduction in human serum.
Nagaoka et al. hydrolyzed bovine P-lactoglobuline with porcine trypsin to obtain peptide IIAEK [41]. This peptide had the highest hypocholesterolemic effect in rats compared to P-sitosterol, a plant microelement with the chemical nature similar to the cholesterol nature and well known for its therapeutic potential, for example, the antioxidant, antidia-betic, anticancer, antihyperlipidemic, immunomodulatory and other effects [42].
When studying the protein profile of raw smoked sausages produced with starter cultures, including those that were capable to reduce the cholesterol level in the culture medium and finished meat products, a change in protein fractions and presumptive formation of BAPs were shown. A wide range of peaks of peptide masses that had certain differences was obtained by MS. Analysis of rat blood serum lipids revealed the highest decrease in the cholesterol concentration in the group with starter culture the composition from the collection of MGUPP (Lactobacillus sakei 104,
Pediococcuspentosaceus 28 and Staphylococcus carnosus 108) compared to the control, mainly, due to a 3 fold decrease in LDL cholesterol (P<0.05) [43,44,45].
5. Peptides with antitumor activity
It is known that several peptides can also show the antitumor activity, inhibit cell proliferation and exert the cytotoxic action on cancer cells [46]. Jang et al. [47] studied the activity of four peptides isolated from beef sarcoplasmic proteins regarding breast, stomach and lung adenocarcinoma cells. The results showed that peptide GFHI had the highest cytotoxic effect on breast cancer cells and reduced viability of stomach adenocarcinoma cells. Peptide GLSDGEWQ showed the inhibitory effect on proliferation of stomach adenocarcinoma cells.
Yu et al. antitumor effect analyzed bioactive peptide-3 (ACBP-3) isolated from goat liver antitumor effect on gastric cancer stem cells (GCSCs) in vitro and in vivo. ACBP-3 decreased the percentage of CD44(+) cells, suppressed the proliferation of the SC (spheroid colonies) cells and inhibited their clone-forming capacity in a dose dependent manner. Tumor formation from GCSCs occurred substantially longer when the cells were treated with ACBP-3 in vivo [48].
6. Peptides with antimicrobial activity
Biologically active peptides with the antimicrobial properties were identified in microorganisms, animals and plants. Antimicrobial peptides of animal origin show the inhibitory activity towards much larger spectrum of microorganisms than those produced by bacteria, while the latter demonstrate higher effectiveness at extremely low concentrations even of the nano level. However, the antimicrobial peptides have certain common properties. A majority of antimicrobial peptides have 50 amino acids and less; about 50% of them are hydrophobic amino acids and often make amphipathic 3-D structures [49,50].
Several peptides with the antimicrobial activity were isolated from beef blood; however, only one study showed the presence of antimicrobial peptides obtained from meat [47]. In this study, Jang et al. [47] isolated four peptides (GLSDGEWQ, GFHI, DFHING and FHG) after hydrolysis of beef sarcoplasmic proteins with commercial enzymes. All peptides were then tested on the antimicrobial activity against six pathogens (Escherichia coli, Pseudomonas aeruginosa, Salmonella typhimurium, Staphylococcus aureus, Bacillus cereus and Listeria monocytogenes). The results showed different antimicrobial effect on one or several bacteria. All peptides were active against P. aeruginosa. Peptide GLSDGEWQ demonstrated the inhibitory action on E. coli, S. typhimurium, B. cereus and L. monocytogenes.
Peptides of the hemoglobin a-chain show the antimicrobial activity after treatment with pepsin. Adje et al. [51] described such action of peptides TKAVEHLDDLPGALSEL-SDLHAHKLRVDPVNFKLLSHSLL and LDDLPGALSELS-DLHAHKLRVDPVNFKLLSHSL of the 67-106 fragment of the hemoglobin a-chain regarding Kocuria luteus, Listeria
innocua, Escherichia coli and Staphylococcus aureus. Daoud et al. described the action of peptide VTLASHLPSDFT-PAVHASLDKFLANVSTVL obtained in the similar way against Micrococcus luteus A270, Listeria innocua, Entero-coccus faecalis, Bacillus cereus, Staphylococcus saprophyticus and Staphylococcus simulans [52].
Catiau et al. determined a minimal number of amino acid residues in a peptide that showed the antimicrobial properties and was isolated from the hemoglobin a-chain. It was tripeptide KYR. The experiments demonstrated the inhibitory activity both against gram-negative microorganisms Escherichia coli, Salmonella enteritidis, and gram-positive ones — Listeria innocua, Micrococcus luteus, Staphylococcus aureus [53].
7. Opioid peptides
Opioid peptides received their name due to their ability to interact with opioid receptors and impact on the nervous system of the body [54]. They can reduce pain similar to opiates and affect an emotional condition. Opioid peptides are endogenous ligands of opiate receptors. There are three main classes of endogenous peptides. Enkephalins are neuropeptides with the morphine-like effect. Leucine-enkephalin H2N-Tyr-Gly-Gly-Phe-Leu-COOH (with the molecular weight of 556) and methionine-enkephalin H2N-Tyr-Gly-Gly-Phe-Met-COOH (with the molecular weight of 574) were discovered in 1975. Dynorphins are peptides that contain a high proportion (almost one third) of basic amino acid residues, in particular lysine and arginine. Dynorphins have up to 41% of hydrophobic residues [55]. The main action of dynorphins is associated with the activation of K-opioid receptors. The dynorphin analgesic effect is six times higher than that of morphine [56]. Endorphins block transmission of pain impulses. The structural formula of endorphin is NH2-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln-COOH. Opioid peptides are involved in regulation of the hormonal activity and influence on the immune system. An effect of opioid peptides on brain function regulation was established [57]. Animal proteins can become a source of opioid peptides [58].
A method for quantitative assessment of opioid peptides dynorphin A1-8 and [Met5]-enkephalin-Arg6-Gly7-Leu8 (MERGL) was described. The quantity of prodynorphin and dynorphin A1-8 increased with the beginning of the inflammatory process in the spinal cord and did not reduce during the inflammation resulted from administration as the inflammatory agent, carra-geenan. The quantity of the enkephalin precursor also increased, more as a result of nerve injury rather than as a response to inflammation [59].
An opioid effect of fragments 143AYFYPEL149 and 144YFYPEL149 of alpha S1 casein, which stimulated gene MUC5A expression, was revealed in the samples of ileum in the experiments on guinea pigs [60].
It was found that several food-derived peptides influence rodent behavior. These peptides can be formed in the process of food digestion and can affect opioid receptors and cross the gastrointestinal and blood-brain barriers without their injury. An increased consumption of peptides from wheat gluten (gliadorphin-7) and milk casein (^-casomorphins) can be a factor linked to the development or maintenance of schizophrenia symptoms. Also, peptides derived from spinach (rubiscolins) and soy (soymorphins) influenced spontaneous behavior and memory [61].
8. Bioavailability of bioactive peptides
For bioavailability assessment it is necessary to determine whether the BAP can reach its target site in an active form and sufficient amount to affect health. The action of gastrointestinal enzymes such as intestinal absorption, cellular uptake and action of blood plasma peptidases, can modify the peptide structure or hydro-lyze them l eading to losses, retention or an increase of bioavailability [62,63,64].
Small peptides are more resistant to destruction by intestinal enzymes and more easily absorbed [65]. Ohara et al. [66] found small peptides obtained from collagen in blood after oral administration of protein hydrolysate products.
On the other hand, cell models, such as heterogeneous monolayers of human epithelial colorectal adenocarcinoma cells (Caco-2 cells) are effective to study transepithelial transport machanisms of peptides [67,68,69].
Shimizu et al. [70] reported that chicken collagen octa-peptide GAXGLXGP can be transported through the human intestinal epithelium. Fu et al. [20] identified two peptides (VGPV and GPRGF) obtained from bovine collage and showed their ACE-I inhibitory activity on human intestinal epithelial Caco-2 cells highlighting bioavailability of these peptides.
An ability of peptides to withstand enzymatic splitting and be transported through intestinal cell membranes into the bloodstream depends on their characteristics, length and amino acid composition. Proline-rich peptides are more resistant to gastrointestinal enzymes. Di- and tripeptides can be absorbed intact by the peptide transport systems and hydrolyzed later [65]. The low transport ability of oligopeptides compared to di- and tripeptides is probably because of their length and may involves the paracellular route, while the hydrophobicity of peptides apparently does not influence the absorption [71].
In addition, the absorption of peptides can be influenced by co-existing peptides and food components, which can share the transport pathway or take part it its regulation [71].
Bioavailability of BAP can also be influenced by the conditions of their processing/storage and food matrix — peptide interactions, which can lead to the modification of peptides with alterations in their native structure and activity [72].
9. Challenges and limitations in the field of BAP research
As the basic principles of bioactive peptide detection are known today, it is necessary to continue research of bioactive peptides to a better understanding of their effects, interactions and bioavailability. Several authors argue that it is necessary to consider seriously interactions of a food matrix, especially when the aim is the use of bioactive peptides as a functional ingredient [72]. More and more often, when a peptide has been identified in a food matrix, it is synthesized and characterized as an individual molecule. However, the expected in vitro and/or in vivo activity can be different, when a peptide interacts with a complex mixture of compounds being a part of the composition of any product. On the other hand, more efforts towards the development of quantitative methodologies are needed to better understanding the processes of peptide hydrolysis, biological activities and/or bioavailability.
Data such as a number of specific naturally generated peptides in an initial food sample or a dose of a bioactive peptide that is necessary for an in vivo effect, as well as final sequences and the quantity in the bloodstream and target organ after gastrointestinal digestion are crucial for assessment of a BAP therapeutic and heeling effect on human health. Detection in a meat sample of the quantity of bioactive peptides that are able to reach a target site in the human body, has a fundamental importance in the studies of bioavailability for a better understanding of effects and mechanisms of action of these peptides. The main limitation for quantification is the nature of a sample: high complexity of a matrix and the fact that small peptides often consist of less than four amino acids at their low concentration in a sample. Modern achievements in mass spectrometry analysis, bioinformatics and updated protein databases facilitate progress in quantitative proteomics [72].
Bioactive peptides obtained from meat are promising candidates for functional ingredients of specialized or healthy foods due to their biological properties [73].
Preparations based on meat peptides with functional groups have not been commercialized by the industry; therefore, foods with functional meat peptides can open a new market of specialized products.
Conclusion
1. The interest to native peptides is to a great extent due to their unusually high biological activity. They exert the potent pharmacological action on many physiological functions of the human body. At the same time, their low stability and rapid decomposition in the body at the physiological pH values were noticed. All this contributed to the development of research on isolation and study of the functional effect of peptides isolated from animal organs and tissues.
2. At present, bioactive peptides with the antioxidant, antithrombotic, antimicrobial, hypotensive, immunomodu-
latory, opioid and other biologically effects, which have curative or preventive impact on pathogenesis of several diseases, have been discovered and studied. Both native amino acid sequences and peptides generated during meat autolysis or enzymolysis, thermal or other technological processing can be functionally active.
3. The peptide activity depends on the amino acid sequence, molecular weight and chain length, type and charge of an amino acid at the N-terminus and C-ter-minus, hydrophobic and hydrophilic properties, spatial structure.
4. Angiotensin-I-converting enzyme (ACE) inhibitory peptides are the most studied meat bioactive peptides due to their effect on blood pressure regulation.
5. Several peptides isolated from meat have the antioxi-dant activity due to their ability to inhibit peroxidation of lipids, chelate metal ions, inactivate free radicals and reactive oxygen species.
6. Peptides that inhibit aggregation of blood platelets are recommended as diet components facilitating prophylaxis of thrombosis, which often occurs in patients with ischemic heart disease or other diseases of the blood circulatory system.
7. Increased cholesterol concentrations in plasma are linked with an increased risk of cardiovascular diseases. Cholesterol enhances lipid peroxidation, protein oxidation and generation of free radicals (H2O2), disrupts the antioxidant system (SOD, CAT, GPx and GSH), as well as the activity of ATPase and causes his-topathological disorders. Bioactive peptides can be regarded as an alternative for prophylaxis or treatment of these conditions.
8. Several bioactive peptides show the antitumor activity, inhibit cell proliferation and exert the cytotoxic action on cancer cells.
9. Antimicrobial peptides of animal origin show the inhibitory activity towards a large spectrum of microorganisms. Several peptides with the antimicrobial activity were isolated from beef blood.
10. Animal proteins can become a source of opioid pep-tides.
11. An ability of peptides to withstand enzymatic denatur-ation and be transported through intestinal cell membranes into the bloodstream depends on their characteristics, length and amino acid composition.
12. The expected in vitro and/or in vivo activity can be different, when a peptide interacts with a complex mixture of compounds being a part of a product composition. Therefore, it is necessary to study interactions in the food matrix, especially when the aim is the use of bio-active peptides as a functional ingredient.
13. Ingredients with functional groups meat peptides that were either formed during technological treatment or already presented in raw meat can open a new market of E-free health promoting foods.
REFERENCES
1. Hayes, M., Stanton, C., Fitzgerald, G.F., Ross, R.P. (2007). Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part II: Bioactive peptide functions. Biotechnology Journal, 2(4), 435-449. https://doi.org/10.1002/ biot.200700045
2. Korhonen, H. (2009). Milk-derived bioactive peptides: From science to applications. Journal of Functional Foods, 1(2), 177187. https://doi.org/10.1016/j.jff.2009.01.007
3. Korhonen, H., Pihlanto, A. (2006). Bioactive peptides: production and functionality. International Dairy Journal, 16(9), 945960. https://doi.org/10.1016/j.idairyj.2005.10.012
4. Ferranti, P., Nitride, Ch., Nicolai, M. A., Mamone, G., Picari-ello, G., Bordoni, A., Valli, V., Nunzio, M.D., Babini, E., Marcolini, E., Capozzi, F. (2014). In vitro digestion of Bresaola proteins and release of potential bioactive peptides. Food Research International, 63, 157-169. https://doi.org/10.1016Zj.foodres.2014.02.008
5. Kitts, D., Weiler, K. (2003). Bioactive Proteins and Peptides from Food Sources. Applications of Bioprocesses used in Isolation and Recovery. Current Pharmaceutical Design, 9(16), 13091323. https://doi.org/10.2174/1381612033454883
6. Chernukha, I.M., Mashentseva, N.G., Afanasyev, D.A., Vostrikova, N.L. (2019). Biologically active peptides of meat proteins and meat products: review. Part 1. General information about biologically active peptides of meat and meat products. Theory and practice of meat processing, 4(4), 12-16. https://doi. org/10.21323/2414-438X-2019-4-4-12-16
7. Li, Y., Yu, J. (2014). Research progress in structure-activity relationship of bioactive peptides. Journal of Medical Food, 18(2), 147-156. https://doi.org/10.1089/jmf.2014.0028
8. Chernukha, I.M., Mashentseva, N.G., Vostrikova, N.L., Kova-lev, L.I., Kovaleva, M.A., Afanasev, D.A., Bazhaev, A.A. (2018). Generation of bioactive peptides in meat raw materials exposed to proteases of different origin. Sel'skokhozyaistvennaya biologiya, 53(6), 1247-1261. DOI: 10.15389/agrobiology.2018.6.1247rus (In Russian)
9. Ahmed, A.M., Mugurama, M. (2010). A review of meat protein hydroly sates and hypertension. Meat Science, 86(1), 110-118. https://doi.org/10.1016/j.meatsci.2010.04.032
10. Albenzio, M., Santillo, A., Caroprese, M., Della Malva, A, Marino, R. (2017). Bioactive Peptides in Animal Food Products. Foods, 6(5), E35. https://doi.org/10.3390/foods6050035
11. Mora, L., Gallego M., Toldra F. (2018). ACEI-Inhibitory pep-tides naturally generated in meat and meat products and their health relevance. Review. Nutrients, 10(9), 1259. https://doi. org/10.3390/nu10091259
12. Sánchez, A., Vázquez, A. (2017). Bioactive peptides: A review. Food Quality and Safety, 1(1), 29-46. https://doi.org/10.1093/ fqs/fyx006
13. Katayama, K., Anggraeni, H.E., Mori, T., Ahhmed, A.M., Kawa-hara, S., Sugiyama, M., Nakayama, T., Maruyama, M., Muguruma, M. (2008). Porcine skeletal muscle troponin is a good source of peptides with angiotensin-I converting enzyme inhibitory activity and antihypertensive effects in spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry, 56(2), 355-360. https://doi.org/10.1021/jf071408j
14. Katayama, K., Tomatsu, M., Fuchu, H., Sugiyama, M., Kawa-hara, S., Yamauchi, K., Kawamura, Y., Muguruma, M. (2003). Purification and characterization of an angiotensin I-converting enzyme inhibitory peptide derived from porcine troponin C. Animal Science Journal, 74(1), 53-58. https://doi.org/10.1046/j.1344-3941.2003.00086.x
15. Escudero, E., Toldrá, F., Sentandreu, M.A., Nishimura, H., Arihara, K. (2012). Anti-hypertensive activity of peptides identified in the in vitro gastrointestinal digest of pork meat. Meat Science, 91(3), 382-384. https://doi.org/10.1016/j.meat-sci.2012.02.007
16. Arihara, K., Nakashima, Y., Mukai, T., Ishikawa, S., Itoh, M. (2001). Peptide inhibitors for angiotensin I-converting enzyme from enzymatic hydrolysates of porcine skeletal muscle proteins. Meat Science, 57(3), 319-324. https://doi.org/10.1016/ s0309-1740(00)00108-x
17. Gómez-Guillén, M.C., Giménez, B., López-Caballero, M.E., Montero, M.P. (2011). Functional and bioactive properties of collagen and gelatin from alternative sources: A review. Food Hy-drocolloids, 25(8), 1813-1827. https://doi.org/10.1016/j.food-hyd.2011.02.007
18. Banerjee, P., Shanthi, C. (2012). Isolation of novel bioac-tive regions from bovine Achilles tendon collagen having an-giotensin I-converting enzyme-inhibitory properties. Process
Biochemistry, 47(12), 2335-2346. https://doi.org/10.1016/j. procbio.2012.09.012
19. Fu, Yu., Young, J.F., Therkildsen, M. (2017). Bioactive pep-tides in beef: Endogenous generation through postmortem aging. Meat Science, 123, 134-142. https://doi.org/10.1016/j.meat-sci.2016.09.015
20. Fu, Yu., Young, J.F., Dalsgaard, T.K., Therkildsen, M. (2015). Separa tion of angiotensin I-converting enzyme inhibitory pep-tides from bovine connective tissue and their stability towards temperature, pH and digestive enzymes. International Journal of Food Science & Technology, 50(5), 1234-1243. https://doi. org/10.1111/ijfs.12771
21. Saiga, A., Iwai, K., Hayakawa, T., Takahata, Y., Kitamura, S., Nishi mura, T., Morimatsu, F. (2008). Angiotensin I-converting enzyme-inhibitory peptides obtained from chicken collagen hy-drolysate. Journal of Agricultural and Food Chemistry, 56(20), 9586-9591.
22. Bezerra, T.K.A., Gomes de Lacerda, J.T.J., Salu, B.R., Oliva, M.L.V., Juliano, M.A., Pacheco, M.T.B., Madruga, M.S. (2019). Identification of Angiotensin I-Converting Enzyme-Inhibitory and Anticoagulant Peptides from Enzymatic Hydrolysates of Chicken Combs and Wattles. Journal of Medicinal Food, 22912), 12941300. https://doi.org/10.1089/jmf.2019.0066
23. Yu, Y., Hu, J., Miyaguchi, Yu., Bai, X., Du, Yu., Lin, B. (2006). Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin. Peptides, 27(11), 2950-2956. https://doi.org/10.1016/j.pep-tides.2006.05.025
24. Zheleznyak, E.V., Khripach, L.V., Knyazeva, T.D., Koganova, Z.I., Zykova, I.E., Grishin, D.A., Revazova, T.L. (2017). DPPH test application the for evaluation of the antioxidant serum activity in field environmental study. Hygiene and sanitation, 96(10), 982-986. https://doi.org/10.18821/0016-9900-2017-96-10-982-986
25. Ames, B. (1983). Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science, 221(4617), 1256-1264. https://doi.org/10.1126/science.6351251
26. Wu, H.C., Sun, B.S., Chang, C.L., Shiau, C.Y. (2005). Low-molecular-weight peptides as related to antioxidant properties of chicken essence. Journal of Food and Drug Analysis, 13(2), 176-183.
27. Kim, E.K., Lee, S.J., Jeon, B.T., Moon, S.H., Kim, B., Park, T.K., Han, J.S., Park P. J. (2009). Purification and characterisation of antioxidative peptides from enzymatic hydrolysates of venison protein. Food Chemistry, 114(4), 1365-1370. https://doi. org/10.1016/j.foodchem.2008.11.035
28. Young, J.F., Therkildsen, M., Ekstrand, B., Che, B.N., Larsen, M.K., Oksbjerg, N., Stagsted, J. (2013). Novel aspects of health promoting compounds in meat. Meat Science, 95(4), 904-911. https://doi.org/10.1016/j.meatsci.2013.04.036
29. Baltic, M., Boskovic, M., Ivanovic, J., Janjic, J., Dokmanovic, M., Markovic, R., Baltic, T. (2014). Bioactive peptides from meat and their influence on human health. Tehnologija Mesa, 55, 8-21. https://doi.org/10.5937/tehmesa1401008b
30. Saiga, A., Tanabe, S., Nishimura, T. (2003). Antioxidant activity of peptides obtained from porcine myofibrillar proteins by protease treatment. Journal of Agricultural and Food Chemistry, 51(12), 3661-3667. https://doi.org/10.1021/jf021156g
31. Arihara, K., Ohata, M. (2006). Functional Properties of Bioactive Peptides Derived from meat Proteins. Chapter 10 in the book «In Advanced Technologies for Meat Processing». Toldra, F., Ed.; Springer: New York, NY, USA, 245-274. https://doi. org/10.1201/9781420017311
32. Li, B., Chen, F., Wang, X., Ji, B., Wu, Y. (2007). Isolation and identification of antioxidative peptides from porcine collagen hy-drolysate by consecutive chromatography and electrospray ion-ization-mass spectrometry. Food Chemistry, 102(4), 1135-1143. https://doi.org/10.1016/j.foodchem.2006.07.002
33. Escudero, E., Mora, L., Fraser, P.D., Aristoy, M.C., Toldrá, F. (2003). Identification of novel antioxidant peptides generated in Spanish dry-cured ham. Food Chemistry, 138(2-3), 1282-1288. https://doi.org/10.1016/j.foodchem.2012.10.133
34. Broncano, J.M., Otte, J., Petrón, M.J., Parra, V., Timón, M.L. (2012). Isolation and identification of low molecular weight an-tioxidant compounds from fermented «chorizo» sausages. Meat Science, 90(2), 494-501. https://doi.org/10.1016/j.meat-sci.2011.09.015
35. Xing, L., Hu, Y., Hu, H., Ge, Q., Zhou, G., Zhang, W. (2016). Purification and identification of antioxidative peptides from dry-
cured Xuanwei ham. Food Chemistry, 194, 951-958. https://doi. org/10.1016/j.foodchem.2015.08.101
36. Iwaniak, A., Minkiewicz, P. (2007). Proteins as the source of physiolo gyically and functionally active peptides. Acta Scien-tiarum Polonorum, Technologia Alimentaria, 6(3), 5-15.
37. Luzak, B., Golanski, J., Rozalski, M., Boncler, M.A., Watala,
C. (2003). Inhibition of collagen-induced platelet reactivity by DGEA peptide. Acta Biochimica Polonica, 50(4), 1119-1128. https://doi.org/10.18388/abp.2003_3636
38. Morimatsu, F., Ito, M., Budijanto, S., Watanabe, I., Furukawa, Y., Kimura, S. (1996). Plasma Cholesterol-Suppressing Effect of Papain-Hydrolyzed Pork Meat in Rats Fed Hypercholesterolemic Diet. Journal of Nutritional Science and Vitaminology, 42(2), 145153. https://doi.org/10.3177/jnsv.42.145
39. Shimizu, M., Sawashita, N., Morimatsu, F., Ichikawa, J., Taguchi, Y., Ijri, Y., Yamamoto, J. (2009). Antithrombotic papain-hydrolyzed peptides isolated from pork meat. Thrombosis research, 123(5), 753-757. https://doi.org/10.1016/j.thromres.2008.07.005
40. González-Ortega, O., López-Limón, A.R., Morales-Domínguez, J.F., Soria-Guerra, R.E. (2015). Production and purification of recombinant hypocholesterolemic peptides. Biotechnology Letters, 37(1), 41-54. https://doi.org/10.1007/s10529-014-1657-4
41. Nagaoka, S., Futamura, Y., Miwa, K., Awano, T., Yamauchi, K., Kanamaru, Y., Tadashi, K., Kuwata, T. (2001). Identification of novel hypocholesterolemic peptides derived from bovine milk P-lactoglobulin. Biochemical and Biophysical Research Communications, 281(1), 11-17. https://doi.org/10.1006/bbrc.2001.4298
42. Sayeed, M.B., Karim, M.R., Sharmin, T., Morshed, M. (2016). Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol. Medicine, 3(4), 29. https://doi.org/10.3390/medi-cines3040029
43. Chernukha, I. M., Mashentseva, N. G., Afanasiev, D. A., Laptev, G. U., Ilina, L. A. (2019). Effect of cholesterol-lowering starter cultures in smoked sausages on the formation of bioactive peptides and lipid profile in triton-induced hyperlipidemic rats. IOP Conference Series: Earth and Environmental Science, 333, 012049. https://doi.org/10.1088/1755-1315/333/1/012049
44. Damodharan, K., Palaniyandi, S.A., Yang, S.H., Suh, J.W. (2016). Functional Probiotic Characterization and In Vivo Cholesterol-Lowering Activity of Lactobacillus helveticus Isolated from Fermented Cow Milk. Journal of Microbiology and Biotechnology 26(10), 1675-1686. https://doi.org/10.4014/jmb.1603.03005
45. Takemura, N., Okubo, T., Sonoyama, K. (2010). Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet. Experimental biology and medicine, 235(7), 849-856. https://doi.org/10.1258/ebm.2010.009377
46. Udenigwe, C.C., Aluko, R.E. (2012). Food Protein-Derived Bioactive Peptides: Production, Processing, and Potential Health Benefits. Journal of Food Science, 77(1), 11-24. https://doi. org/10.1111/j.1750-3841.2011.02455.x
47. Jang, A., Jo, C., Kang, K.S., Lee, M. (2008). Antimicrobial and human cancer cell cytotoxic effect of synthetic angiotensin-con-verting enzyme (ACE) inhibitory peptides. Food Chemistry, 107(1), 327-336. https://doi.org/10.1016/j.foodchem.2007.08.036
48. Yu, L., Yang, L., An, W., Su, X. (2014). Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells. Journal of Cellular Biochemistry, 115(4), 697-711. https://doi.org/10.1002/jcb.24711
49. Rydlo, T, Miltz, J, Mor, A. (2006). Eukaryotic antimicrobial peptides: promises and premises in food safety. Journal of Food Science, 71(9), R125-R135. https://doi.org/10.1111/j.1750-3841.2006.00175.x
50. Nagao, J.I., Asaduzzaman, S.M., Aso, Y., Okuda, K.I., Nakaya-ma, J., Sonomoto, K. (2006). Lantibiotics: insight and foresight for new paradigm. Journal of Bioscience and Bioengineering, 102(3), 139-149. https://doi.org/10.1263/jbb.102.139
51. Adje, E.Y., Balti, R., Kouach, M., Guillochon, D., Nedjar-Ar-roume, N. (2011). a 67-106 of bovine hemoglobin: a new family of antimicrobial and angiotensin I-converting enzyme inhibitory peptides. European Food Research and Technology, 232(4), 637646. https://doi.org/10.1007/s00217-011-1430-z
52. Daoud, R., Dubois, V., Bors-Dodita, L., Nedjar-Arroume, N., Kri-er, F., Chihib, N. E., Marya, P., Kouach, M., Briand, G., Guillochon,
D. (2005). New antibacterial peptide derived from bovine hemoglobin. Peptides, 26(5), 713-719. https://doi.org/10.1016/j. peptides.2004.12.008
53. Catiau, L., Traisnel, J., Delval-Dubois, V., Chihib, N.E., Guillo-chon, D., Nedjar-Arroume, N. (2011). Minimal antimicrobial peptid-ic sequence from hemoglobin alpha-chain: KYR. Peptides, 32(4), 633-638. https://doi.org/10.1016/j.peptides.2010.12.016
54. Tomé, D., Pichon, D., Benjamin, L., Guesdon, G. (2005). Opioid Peptides. Book Chapter in Nutraceutical Proteins and Peptides in Health and Disease, 1, 367. https://doi. org/10.1201/9781420028836.sec4
55. Marinova, Z., Vukojevic, V., Surcheva, S., Yakovleva, T., Cebers, G., Pasikova, N., Usynin, I., Hugonin, L., Fang, W., Hallberg, M., Hirschberg, D., Bergman, T., Langel, U., Hauser, K.F., Pramanik, A., Aldrich, J.V., Gräslund, A., Terenius, L., Bakalkin, P. (2005). Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission. The Journal of Biological Chemistry, 280(28), 26360-26370. https://doi.org/10.1074/jbc.m412494200
56. Han, J.S., Xie, C.W. (1982). Dynorphin: potent analgesic effect in spinal cord of the rat. Life sciences, 31(16-17), 1781-1784. https://doi.org/10.1016/0024-3205(82)90209-0
57. Przewlocki, R. (2015). Opioid Peptides. Book Chapter in Neurosci ence in the 21st Century. New York: Springer. 1-28 p. https://doi.org/10.1007/978-1-4614-6434-1_54-3
58. Garg, S., Nurgali, K., Mishra, V.K. (2016). Food Proteins as Source of Opioid Peptides-A Review. Current Medicinal Chemistry, 23(9), 893-910. https://doi.org/10.2174/0929867323666 160219115226
59. Sapio, M.R., Iadarola, M.J., Loydpierson, A.J., Kim, J.J., Thi-erry-Mieg, D., Thierry-Mieg, J., Maric, D., Mannes, A.J. (2020). Dynorphin and Enkephalin Opioid Peptides and Transcripts in Spinal Cord and Dorsal Root Ganglion During Peripheral Inflammatory Hyperalgesia and Allodynia. The Journal of pain, https://doi. org/10.1016/j.jpain.2020.01.001
60. Fernández-Tomé, S., Martínez-Maqueda, D., Girón, R., Goicoe-chea, C., Miralles, B., Recio, I. (2016). Novel peptides derived from as1-casein with opioid activity and mucin stimulatory effect on HT29-MTX cells. Journal of Functional Foods, 25, 466-476. https://doi.org/10.1016/j.jff.2016.06.023
61. Lister, J., Fletcher, P.J., Nobrega, J.N., Remington, G. (2015). Behavioral effects of food-derived opioid-like peptides in rodents: Implications for schizophrenia? Pharmacology Biochemistry and Behavior, 134, 70-78. https://doi.org/10.1016/j. pbb.2015.01.020
62. Hernández-Ledesma, B., del Mar Contreras, M., Recio, I. (2011). Antihy pertensive peptides: Production, bioavailabil-ity and incorporation into foods. Advances in colloid and interface science, 165(1), 23-35. https://doi.org/10.1016/j. cis.2010.11.001
63. Vermeirssen, V., Camp, J. V., Verstraete, W. (2004). Bio-availability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition, 92(3), 357-366. https://doi. org/10.1079/bjn20041189
64. Ryan, J.T., Ross, R.P., Bolton, D., Fitzgerald, G.F., Stanton, C. (2011). Bioactive peptides from muscle sources: Meat and fish. Nutrients, 3(9), 765-791. https://doi.org/10.3390/nu3090765
65. Segura-Campos, M., Chel-Guerrero, L., Batancur-Ancona, D., Hernandez-Escalante, V.M. (2011). Bioavailability of bioac-tive peptides. Food Reviews International, 27(3), 213-226. https://doi.org/10.1080/87559129.2011.563395
66. Ohara, H., Matsumoto, H., Itoh, K., Iwai, K., Sato, K. (2007). Comparison of Quantity and Structures of Hydroxyproline-Con-taining Peptides in Human Blood after Oral Ingestion of Gelatin Hydrolysates from Different Sources. Journal of Agricultural and Food Chemistry, 55(4), 1532-1535. https://doi.org/10.1021/ jf062834s
67. Fu, Y., Young, J.F., Rasmussen, M.K., Dalsgaard, T.K., Lametsch, R., Aluko, R.E., Therkildsen, M. (2016). Angioten-sin I-converting enzyme-inhibitory peptides from bovine collagen: insights into inhibitory mechanism and transepithelial transport. Food Research International, 89, 373-381. https://doi. org/10.1016/j.foodres.2016.08.037
68. Gallego, M., Grootaert, C., Mora, L., Aristoy, M.C., Camp, J. V., Toldrá, F. (2016). Transepithelial transport of dry, cured ham peptides with ACE inhibitory activity through a Caco-2 cell mono-layer. Journal of Functional Foods, 21, 388-395. https://doi. org/10.1016/j.jff.2015.11.046
69. Sangsawad, P., Choowongkomon, K., Kitts, D.D., Chen, X.M., Li-Chan, E.C.Y., Yongsawatdigul, J. (2018). Transepithelial transport and structural changes of chicken angiotensin I-convertin Genzyme (ACE) inhibitory peptides through Caco-2 cell mono-layers. Journal of Functional Foods, 45, 401-408. https://doi. org/10.1016/j.jff.2018.04.020
70. Shimizu, K., Sato, M., Zhang, Y., Kouguchi, T., Takahata, Y., Morimatsu, F., Shimizu, M. (2010). The Bioavailable Octapep-tide Gly-Ala-Hyp-Gly-Leu-Hyp-Gly-Pro Stimulates Nitric Oxide Synthesis in Vascular Endothelial Cells. Journal of Agricultural and
Food Chemistry, 58(11), 6960-6965. https://doi.org/10.1021/ jf100388w
71. Shen, W., Matsui, T. (2017). Current knowledge of intestinal absorption of bioactive peptides. Food & function, 8(12), 43064314. https://doi.org/10.1039/c7fo01185g
72. Udenigwe, C.C., Fogliano, V. (2017). Food matrix interaction and bioavailability of bioactive peptides: Two faces of the
same coin? Journal of Functional Foods, 35, 9-12. https://doi. org/10.1016/j.jff.2017.05.029
73. Hartmann, R., Meisel, H. (2007). Food-derived peptides with biological activity: From research of old applications. Current Opinion in Biotechnology, 18(2), 163-169. https://doi. org/10.1016/j.copbio.2007.01.013
AUTHOR INFORMATION
Irina M. Chernukha — doctor of technical sciences, professor, Academician of Russian Academy of Sciences, principal research scientist, Experimental clinic-laboratory «Biologically active substances of animal origin», V. M. Gorbatov Federal Research Center for Food Systems of Russian Academy of Sciences. 109316, Moscow, Talalikhina str., 26. Tel: +7-495-676-63-21. E-mail: imcher@inbox.ru ORCID: https://orcid.org/0000-0003-4298-0927
Natal'ya G. Mashentseva — doctor of technical sciences, professor RAS, head of the Department of Biotechnology and Technology of Products of Bioorganic Synthesis, Moscow state university of food production. 125080, Moscow, Volokolamskoe sh., 11. Tel.: +7-499-811-00-03, ext. 6883. E-mail: natali-mng@yandex.ru ORCID: https://orcid.org/0000-0002-9287-0585 * corresponding author
Dmitrii A. Afanas'ev — student, Institute of Innovative Technologies and Bioindustry of Food Products, Moscow State University of Food Pro-duction.125080, Moscow, Volokolamskoe sh., 11. Tel.: +7-985-456-77-82. E-mail: dmitr.afanasjew2010@yandex.ru ORCID: https://orcid.org/0000-0002-7463-4503
Natal'ya L. Vostrikova — doctor of technical sciences, head of laboratory «Center for food and feed testing», V. M. Gorbatov Federal Research Center for Food Systems of Russian Academy of Sciences. 109316, Moscow, Talalikhina str., 26. Tel.: +7-495-676-79-81. E-mail: n.vostrikova@fncps.ru ORCID: https://orcid.org/0000-0002-9395-705X
All authors bear responsibility for the work and presented data.
All authors made an equal contribution to the work.
The authors were equally involved in writing the manuscript and bear the equal responsibility for plagiarism. The authors declare no conflict of interest.
Received 05.04.2020 Accepted in revised 21.04.2020 Accepted for publication 20.05.2020
